Article focuses on ISMP’s alert regarding mix-ups between the pediatric formulation of the Pfizer-BioNTech COVID-19 vaccine in children 5 to 11 years of age and the formulation for individuals 12 years of age or older.
For the full text, visit Specialty Pharmacy Continuum online. Please note that access may require free registration.
